MedPath
NMPA Approval

Adalimumab Solution for Injection

国药准字SJ20215002

March 15, 2021

S20191006

Drug Information

阿达木单抗注射液

修美乐

注射剂

预填充式注射器装:80mg(0.8ml)/支

生物制品

March 15, 2021

November 14, 2024

Company Information

Applicant Company

Knollstrasse, 67061 Ludwigshafen, Germany

Manufacturing Company

vetter pharma-fertigung gmbh & co.kg

Schützenstrasse 87 and 99-101,88212 Ravensburg,Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿达木单抗注射液 - NMPA 批准文号 | MedPath